HEADER HORMONE RECEPTOR 30-JUN-11 2LFG TITLE SOLUTION STRUCTURE OF THE HUMAN PROLACTIN RECEPTOR ECD DOMAIN D2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROLACTIN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FIBRONECTIN TYPE-III 2 DOMAIN RESIDUES 99-210; COMPND 5 SYNONYM: PRL-R; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET11A KEYWDS EXTRACELLULAR DOMAIN, CYTOKINE RECEPTOR, HORMONE RECEPTOR EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.DAGIL,M.J.KNUDSEN,B.B.KRAGELUND,C.O'SHEA,K.TEILUM REVDAT 3 14-JUN-23 2LFG 1 REMARK SEQADV REVDAT 2 22-FEB-12 2LFG 1 JRNL REVDAT 1 15-FEB-12 2LFG 0 JRNL AUTH R.DAGIL,M.J.KNUDSEN,J.G.OLSEN,C.O'SHEA,M.FRANZMANN,V.GOFFIN, JRNL AUTH 2 K.TEILUM,J.BREINHOLT,B.B.KRAGELUND JRNL TITL THE WSXWS MOTIF IN CYTOKINE RECEPTORS IS A MOLECULAR SWITCH JRNL TITL 2 INVOLVED IN RECEPTOR ACTIVATION: INSIGHT FROM STRUCTURES OF JRNL TITL 3 THE PROLACTIN RECEPTOR JRNL REF STRUCTURE V. 20 270 2012 JRNL REFN ISSN 0969-2126 JRNL PMID 22325776 JRNL DOI 10.1016/J.STR.2011.12.010 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AUTOASSIGN 2.3.0, X-PLOR NIH REMARK 3 AUTHORS : ZIMMERMAN, MOSELEY, KULIKOWSKI AND MONTELIONE REMARK 3 (AUTOASSIGN), SCHWIETERS, KUSZEWSKI, TJANDRA AND REMARK 3 CLORE (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000102326. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, 10 MM SODIUM PHOSPHATE, REMARK 210 10 MM TCEP, 1 MM DSS, 0.02 % REMARK 210 SODIUM AZIDE, 90% H2O/10% D2O; REMARK 210 0.5 MM [U-100% 13C(1)] PROTEIN, REMARK 210 10 MM SODIUM PHOSPHATE, 10 MM REMARK 210 TCEP, 0.02 % SODIUM AZIDE, 1 MM REMARK 210 DSS, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D C(CO)NH; 3D HNCO; 3D HNCA; 3D REMARK 210 HNCACB; 3D HN(CO)CA; 3D H(CCO)NH; REMARK 210 3D CBCA(CO)NH; 3D HN(CA)CO; 3D REMARK 210 1H-15N NOESY; 3D 1H-15N TOCSY; REMARK 210 3D HCCH-TOCSY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 2D 1H-13C HSQC AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.2.1, X-PLOR NIH 2.25, REMARK 210 TALOS, NMRDRAW, CCPN 2.1.5, ARIA REMARK 210 2.3.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 103 -82.00 -73.93 REMARK 500 1 PRO A 106 92.19 -69.11 REMARK 500 1 LEU A 109 96.28 -67.68 REMARK 500 1 LEU A 132 -170.57 64.04 REMARK 500 1 ILE A 133 -70.58 64.70 REMARK 500 1 ASP A 134 87.10 57.93 REMARK 500 1 LEU A 135 47.12 -77.77 REMARK 500 1 LYS A 149 145.53 -170.17 REMARK 500 1 SER A 192 14.80 -146.38 REMARK 500 1 SER A 195 -54.96 -171.43 REMARK 500 2 GLN A 102 74.35 -118.77 REMARK 500 2 PRO A 103 -161.19 -101.37 REMARK 500 2 GLN A 163 -46.18 72.60 REMARK 500 2 TRP A 194 171.96 69.20 REMARK 500 2 SER A 195 -57.58 -159.64 REMARK 500 2 ASN A 209 57.47 -101.24 REMARK 500 3 PRO A 106 94.82 -69.50 REMARK 500 3 ASP A 134 79.36 56.99 REMARK 500 3 LYS A 149 149.89 -172.45 REMARK 500 3 TYR A 190 -164.83 -163.17 REMARK 500 3 TRP A 191 129.35 -30.03 REMARK 500 3 ALA A 193 -157.83 58.09 REMARK 500 3 ASP A 205 32.92 -92.21 REMARK 500 3 MET A 208 -71.13 -114.12 REMARK 500 4 PRO A 103 99.19 -66.80 REMARK 500 4 PRO A 130 86.90 -64.70 REMARK 500 4 THR A 131 -95.22 56.86 REMARK 500 4 ILE A 133 -76.65 67.90 REMARK 500 4 GLN A 163 -33.36 -179.52 REMARK 500 4 SER A 192 41.05 -142.63 REMARK 500 4 ALA A 193 -172.27 67.62 REMARK 500 4 SER A 195 -53.89 -156.07 REMARK 500 4 ASP A 205 34.56 -94.20 REMARK 500 5 TYR A 99 127.95 68.82 REMARK 500 5 PRO A 130 135.63 -38.57 REMARK 500 5 ILE A 133 -53.03 70.39 REMARK 500 5 TRP A 139 -65.92 69.34 REMARK 500 5 GLN A 163 52.99 -91.67 REMARK 500 5 SER A 195 -57.88 -137.02 REMARK 500 5 MET A 208 -61.65 -139.28 REMARK 500 6 PRO A 103 -81.33 -72.79 REMARK 500 6 PRO A 116 -83.99 -68.10 REMARK 500 6 GLU A 117 -77.44 -175.17 REMARK 500 6 ASP A 134 79.52 58.69 REMARK 500 6 THR A 165 36.49 -96.48 REMARK 500 6 TYR A 190 -168.53 -163.81 REMARK 500 6 ALA A 193 -152.72 58.32 REMARK 500 7 ASP A 104 57.35 34.89 REMARK 500 7 ILE A 133 -65.18 -97.28 REMARK 500 7 ASP A 134 87.28 64.12 REMARK 500 REMARK 500 THIS ENTRY HAS 153 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RW5 RELATED DB: PDB REMARK 900 HUMAN PROLACTIN REMARK 900 RELATED ID: 3EW3 RELATED DB: PDB REMARK 900 2:1 COMPLEX REMARK 900 RELATED ID: 3NPZ RELATED DB: PDB REMARK 900 2:1 COMPLEX REMARK 900 RELATED ID: 3D48 RELATED DB: PDB REMARK 900 1:1 COMPLEX REMARK 900 RELATED ID: 3MZG RELATED DB: PDB REMARK 900 1:1 COMPLEX REMARK 900 RELATED ID: 17752 RELATED DB: BMRB DBREF 2LFG A 99 210 UNP P16471 PRLR_HUMAN 123 234 SEQADV 2LFG MET A 98 UNP P16471 INITIATING METHIONINE SEQRES 1 A 113 MET TYR ILE VAL GLN PRO ASP PRO PRO LEU GLU LEU ALA SEQRES 2 A 113 VAL GLU VAL LYS GLN PRO GLU ASP ARG LYS PRO TYR LEU SEQRES 3 A 113 TRP ILE LYS TRP SER PRO PRO THR LEU ILE ASP LEU LYS SEQRES 4 A 113 THR GLY TRP PHE THR LEU LEU TYR GLU ILE ARG LEU LYS SEQRES 5 A 113 PRO GLU LYS ALA ALA GLU TRP GLU ILE HIS PHE ALA GLY SEQRES 6 A 113 GLN GLN THR GLU PHE LYS ILE LEU SER LEU HIS PRO GLY SEQRES 7 A 113 GLN LYS TYR LEU VAL GLN VAL ARG CYS LYS PRO ASP HIS SEQRES 8 A 113 GLY TYR TRP SER ALA TRP SER PRO ALA THR PHE ILE GLN SEQRES 9 A 113 ILE PRO SER ASP PHE THR MET ASN ASP HELIX 1 1 PRO A 203 THR A 207 5 5 SHEET 1 A 3 LEU A 107 LYS A 114 0 SHEET 2 A 3 TYR A 122 SER A 128 -1 O TRP A 124 N GLU A 112 SHEET 3 A 3 GLU A 166 ILE A 169 -1 O PHE A 167 N ILE A 125 SHEET 1 B 4 GLU A 157 GLY A 162 0 SHEET 2 B 4 TYR A 144 PRO A 150 -1 N ILE A 146 O HIS A 159 SHEET 3 B 4 GLN A 176 CYS A 184 -1 O LEU A 179 N LYS A 149 SHEET 4 B 4 THR A 198 ILE A 202 -1 O ILE A 200 N TYR A 178 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1